BlackRock Investment Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

BlackRock Investment Management’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,154	Closed	-$223K	–	4198
2015 Q3	$223K	Buy	5,154 +64	+1%	+$2.7K	﹤0.01%	3234
2015 Q2	$215K	Buy	+5,090	New	+$215K	﹤0.01%	3263

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

BlackRock Investment Management's WX Position: Q4 2015 in Review

BlackRock Investment Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 5,154 shares — an estimated $223K sold.

BlackRock Investment Management first reported a position in WX in Q2 2015 and held it in 2 quarters. The position peaked at $223K in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

BlackRock Investment Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
BlackRock Investment Management sold 5,154 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $223K.
BlackRock Investment Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2015 and held it in 2 quarters.
BlackRock Investment Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $223K in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on BlackRock Investment Management's 13F filing for Q4 2015, filed 11 Feb 2016.